LAUSR

1. Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135:1924–1934, 1934.e1921–1924. 2. Stirnimann G, Kessebohm K, Lauterburg B. Liver injury caused by drugs: an update. SwissMedWkly. 2010;140:w13080. 3. Biour M, Ben CS, Chazouillères O, et al. Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs [in French]. Gastroenterol Clin Biol. 2004;28:720–759. 4. Smith T, Kawa K, Eckl V, et al. Herbal supplement sales in US increase 7.7% in 2016. Herbalgram. 2017;115:56–65. 5. Lukefahr AL, McEvoy S, Alfafara C, et al. Drug-induced autoimmune hepatitis associated with turmeric dietary supplement use. BMJ Case Rep. 2018;2018:1–5. 6. Ostapowicz G, Fontana RJ, Schiødt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002; 137:947–954. 7. Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis. 2000;4:73–96, vi. 8. Davern TJ. Drug-induced liver disease. Clin Liver Dis. 2012;16:231–245. 9. Yuan L, Kaplowitz N. Mechanisms of drug-induced liver injury. Clin Liver Dis. 2013;17:507–518.vii. 10. Zhang X, Ouyang J, Thung SN. Histopathologic manifestations of drug-induced hepatotoxicity. Clin Liver Dis. 2013;17:547–564.vii–viii. 11. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006;354:731–739. 12. Avigan MI, Mozersky RP, Seeff LB. Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States. Int J Mol Sci. 2016;17:331. 13. Navarro VJ, Barnhart H, Bonkovsky HL, et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 2014;60: 1399–1408. 14. Balaji S, Chempakam BJF. Toxicity prediction of compounds from turmeric (Curcuma longa L). Food Chem Toxicol. 2010;48:2951–2959. 15. Sasaki T, Suzuki Y, Ishida K, et al. Autoimmune hepatitis following influenza virus vaccination: two case reports. Medicine (Baltimore). 2018;97:e11621. 16. Berry PA, Smith-Laing G. Hepatitis A vaccine associated with autoimmune hepatitis. World J Gastroenterol. 2007; 13:2238–2239. 17. Perumalswami P, Peng L, Odin JA. Vaccination as a triggering event for autoimmune hepatitis. Semin Liver Dis. 2009;29:331–334. 18. Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol. 1993;46:1331–1336. 19. Hautekeete ML, Colle I, van Vlierberghe H, et al. Symptomatic liver injury probably related to sertraline. Gastroenterol Clin Biol. 1998;22:364–365.